Alexander A. Oliver

Alexander A. Oliver

Auto-generated profile, based on publicly available information

Alexander A. Oliver

Department of Radiology, Mayo Clinic, Rochester, MN, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Acta Biomaterialia
Verified
Journal Article
Closed access
AOAlexander A. Oliver
Alexander A. Oliver
MSMalgorzata Sikora-Jasinska
Malgorzata Sikora-Jasinska
ADAli Gökhan Demir
Ali Gökhan Demir
RGRoger J. Guillory
Roger J. Guillory

31 March 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
RGRoger J. Guillory
Roger J. Guillory
EMEhsan Mostaed
Ehsan Mostaed
AOAlexander A. Oliver
Alexander A. Oliver
LMLea Morath
Lea Morath
EEElisha J. Earley
Elisha J. Earley
JGJeremy Goldman
Jeremy Goldman

24 September 2020 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
AOAlexander A. Oliver
Alexander A. Oliver
RGRoger J. Guillory
Roger J. Guillory
KFKatie L. Flom
Katie L. Flom
LMLea M. Morath
Lea M. Morath
TKTimothy M. Kolesar
Timothy M. Kolesar
JGJeremy Goldman
Jeremy Goldman

18 November 2021 in Bioactive Materials
Verified
Journal Article
Open access
MSMalgorzata Sikora-Jasinska
Malgorzata Sikora-Jasinska
LMLea Morath
Lea Morath
MKMaria Paula Kwesiga
Maria Paula Kwesiga
MPMargaret E. Plank
Margaret E. Plank
ANAlexia L. Nelson
Alexia L. Nelson
JGJeremy Goldman
Jeremy Goldman
Biodegradable stents have tremendous theoretical potential as an alternative to bare metal stents and drug-eluting stents for the treatment of obstructive coronary artery disease. Any bioresorbable or biodegradable scaffold material needs to possess optimal mechanical properties and uniform degradation behavior that avoids local and systemic toxicity. Recently, molybdenum (Mo) has been investigated as a potential novel biodegradable material for this purpose. With its proven moderate degradation rate and excellent mechanical properties, Mo may represent an ideal source material for clinical cardiac and vascular applications. The present study was performed to evaluate the mechanical performance of metallic Mo in vitro and the biodegradation properties in vivo. The results demonstrated favorable mechanical behavior and a uniform degradation profile as desired for a new generation ultra-thin degradable endovascular stent material. Moreover, Mo implants in mouse arteries avoided the typical cellular response that contributes to restenosis. There was minimal neointimal hyperplasia over 6 months, an absence of excessive smooth muscle cell (SMC) proliferation or inflammation near the implant, and avoidance of significant harm to regenerating endothelial cells (EC). Qualitative inspection of kidney sections showed a potentially pathological remodeling of kidney Bowman's capsule and glomeruli, indicative of impaired filtering function and development of kidney disease, although quantifications of these morphological changes were not statistically significant. Together, the results suggest that the products of Mo corrosion may exert beneficial or inert effects on the activities of inflammatory and arterial cells, while exerting potentially toxic effects in the kidneys that warrant further investigation.

30 May 2022 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
AOAlexander A Oliver
Alexander A Oliver
KCKent D Carlson
Kent D Carlson
CBCem Bilgin
Cem Bilgin
JLJorge L Arturo Larco
Jorge L Arturo Larco
RKRam Kadirvel
Ram Kadirvel
DKDavid F Kallmes
David F Kallmes
The use of flow diverters is a rapidly growing endovascular approach for the treatment of intracranial aneurysms. All FDA-approved flow diverters are composed of nitinol or cobalt-chromium, which will remain in the patient for the duration of their life. Bioresorbable flow diverters have been proposed by several independent investigators as the next generation of flow diverting devices. These devices aim to serve their transient function of occluding and healing the aneurysm prior to being safely resorbed by the body, eliminating complications associated with the permanent presence of conventional flow diverters. Theoretical advantages of bioresorbable flow diverters include (1) reduction in device-induced thrombosis; (2) reduction in chronic inflammation and device-induced stenosis; (3) reduction in side branch occlusion; (4) restoration of physiological vasomotor function; (5) reduction in imaging artifacts; and (6) use in pediatric applications. Advances made in the similar bioresorbable coronary stenting field highlight some of these advantages and demonstrate the feasibility and safety of bioresorbable endovascular devices in the clinic. The current work aims to review the progress of bioresorbable flow diverters, identify opportunities for further investigation, and ultimately stimulate the advancement of this technology.

30 August 2024 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
DPDan Adrian Popica
Dan Adrian Popica
JCJonathan Cortese
Jonathan Cortese
AOAlexander A Oliver
Alexander A Oliver
VPVincent Plaforet
Vincent Plaforet
IDIgnacio Molina Diaz
Ignacio Molina Diaz
LSLaurent Spelle
Laurent Spelle
Background Although flow diverters (FDs) have benefited from several technical improvements, recently concerns have arisen regarding the braid stability after implantation. Thus, we investigated frequency, predictive factors, and clinical impact of the phenomenon of FD braid deformation (FDBD). Methods Consecutive intracranial aneurysms (IAs) treated with various FDs, between January 2018 and July 2023, were reviewed to identify FDBD (defined as the deformation of a FD without any external force applied to it). Patient, aneurysm, procedural, and FD characteristics were retrieved and analyzed using univariate and multivariable analyses. Morbidity is defined as a score of +1 in the modified Rankin Scale at 3 months. Results In total, 245 FD procedures (271 FDs implanted; 25 multiple IAs treated with 1 FD) in 228 patients; FDBD was observed in 36/245 cases (14.7%), mainly at follow-up angiography (32/36, 88.9%); fish-mouthing was the most frequent FDBD. Morbidity was related to fish-mouthing and braid collapse and was significantly higher in the FDBD group after retreatment (p=0.04). Drawn filled tubing with platinum (DFT) (adjusted odds ratio (aOR)=7.0, 95% CI 3.0 to 17.5; p<0.001) and FD diameter (aOR=2.2, 95% CI 1.3 to 4.1; p<0.01) were identified as independent predictors of FDBD. The metal alloy composing the FD (p=0.13) and coated surfaces were not significantly associated with FDBD (p=0.54 in multivariable analysis). Conclusions FDBD is a frequent phenomenon observed in about 15% of cases, and it was responsible for higher morbidity. Only FD characteristics (DFT and FD diameter) were independent determinants of FDBD. Future research should focus on the impact of novel braid configurations and materials on braid stability.